Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicinal composition for treating pulmonary tuberculosis, and preparation method and use thereof

A tuberculosis and composition technology, applied in the field of pharmaceutical composition for the treatment of tuberculosis and its preparation, can solve the problems of slow effect, loss of working ability, long treatment cycle, etc., and achieve significant curative effect, low cost and quick effect

Inactive Publication Date: 2016-03-09
吴申龙
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis, which can invade many organs. Tuberculosis infection in the lungs is the most common, and bacteria excretors are the important source of infection. The initial clinical manifestations are chronic cough, less sputum, and flushing. Fever, night sweats, weight loss occasionally, middle-term health aggravated to physical weakness, a large number of hemoptysis, and a wide range of respiratory symptoms. At present, with the increasing air pollution, the epidemic form of tuberculosis is severe, and tuberculosis spreads through the respiratory tract , highly contagious, seriously endangering the health of others, if it is not treated thoroughly and in time, it will lose the ability to work and even die. The trend of tuberculosis is high infection, high disease, high drug resistance, and high death; Chinese medicine believes that the cause of tuberculosis is infection Tuberculosis, but the onset has a lot to do with the strength of righteousness. The main location of the disease is in the lungs. Western medicine mostly uses streptomycin and rifampicin for treatment, but the curative effect is poor, it is easy to repeat, and the side effects are large, and it is easy to develop drug resistance. , but the simple use of traditional Chinese medicine treatment, the effect is relatively slow, the treatment cycle is long, and it is difficult for patients to insist on taking the medicine; based on the above reasons, it is necessary to propose a drug with small side effects, significant curative effect, and short treatment cycle to improve the therapeutic effect of tuberculosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] A pharmaceutical composition for treating pulmonary tuberculosis, which is made of the following components in parts by weight: 5 parts of Adenophora pilosula, 2 parts of Baibu, 5 parts of Pulsatilla chinensis, 10 parts of Cat's Claw, 5 parts of Euonymus microphyll, 2 parts of Digupi 0 parts of centipede, 10 parts of Chidili, 4 parts of sugar mustard, 7 parts of Tianjie shell, 3 parts of Ziheche, 12 parts of Xiantao grass, 2 parts of Chuan Fritillaria, 10 parts of antler gum, 3 parts of turtle shell, 5 parts of watermelon seedlings, 5 parts of Poria cocos, 4 parts of Meconopsis safflower, 10 parts of oysters, 15 parts of Tinglizi, 0.1 part of pig lung extract.

Embodiment 2

[0054] A pharmaceutical composition for treating pulmonary tuberculosis, which is made of the following components in parts by weight: 10 parts of Adenophora, 8 parts of Baibu, 7 parts of Pulsatilla chinensis, 15 parts of Cat's Claw, 15 parts of Euonymus microphyll, 6 parts of Digupi 5 parts of centipede, 12 parts of Chidili, 10 parts of candied mustard, 11 parts of Tianjie shell, 5 parts of Ziheche, 15 parts of Xiantao grass, 4 parts of Chuan Fritillaria, 15 parts of antler gum, 5 parts of turtle shell, wild 12 parts of watermelon seedlings, 7 parts of Poria cocos, 10 parts of Meconopsis safflower, 20 parts of oysters, 25 parts of Tinglizi, 0.5 parts of pig lung extract.

Embodiment 3

[0056] A pharmaceutical composition for treating pulmonary tuberculosis, which is made of the following components in parts by weight: 7 parts of Adenophora, 5 parts of Baibu, 6 parts of Pulsatilla, 12 parts of Cat's Claw, 10 parts of Euonymus microphyll, 4 parts of Digupi 3 parts of centipede, 11 parts of Chidili, 7 parts of candied mustard, 9 parts of Tianjie shell, 4 parts of Ziheche, 13 parts of Xiantao grass, 3 parts of Chuan Fritillaria, 12 parts of antler gum, 4 parts of turtle shell, wild 8 parts of watermelon seedlings, 6 parts of Poria cocos, 7 parts of Meconopsis safflower, 15 parts of oysters, 20 parts of Tinglizi, 0.3 parts of pig lung extract.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Average ageaaaaaaaaaa
Login to View More

Abstract

The invention discloses a medicinal composition for treating pulmonary tuberculosis, and a preparation method and a use thereof. The medicinal composition is prepared from Radix Glehniae, Radix Stemonae, Anemone chinensis, Radix Ranunculi Ternati, Common Boxwood, Cortex Lycii, centipedes, Fagopyrum cymosum, Orange Sugarmustard, Metaplexis japonica (Thunb.) Makino, Human Placenta, Veronica peregrina L., Fritillaria cirrhosa, deerhorn glue, turtle shell, Hibiscus trionum, Poria cocos, Meconopsis punicea, oyster, tingli seed and pork lung extract; the pork lung extract is one or more of phosphatidylcholine, dipalmitoylphosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol and sphingomyelin; and the effective component of Common Boxwood is cycloprotobuxinamin. The medicinal composition adopting traditional Chinese medicine and western medicine combination has the efficacies of moistening lung and relieving coughs, clearing heat and eliminating inflammation, cooling blood and stopping bleeding, and eliminating swelling and relieving pains, and has the advantages of substantial pulmonary tuberculosis treatment effect, safety, reliability, no toxic or side effects, short treatment course, fast effectiveness, low cost, and reaching of the purpose of simultaneous treatment of principal and subordinate symptoms.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a pharmaceutical composition for treating pulmonary tuberculosis and its preparation method and application. Background technique [0002] Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis, which can invade many organs. Tuberculosis infection in the lungs is the most common, and bacteria excretors are the important source of infection. The initial clinical manifestations are chronic cough, less sputum, and flushing. Fever, night sweats, weight loss occasionally, middle-term health aggravated to physical weakness, a large number of hemoptysis, and a wide range of respiratory symptoms. At present, with the increasing air pollution, the epidemic form of tuberculosis is severe, and tuberculosis spreads through the respiratory tract , highly contagious, seriously endangering the health of others, if it is not treated thoroughly and in time, it will lose the abi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/904A61P11/00A61P31/06A61K35/648A61K35/50A61K35/32A61K35/586A61K35/618A61K35/42A61K31/685A61K31/683A61K31/688A61K31/57C07J53/00
CPCA61K31/57A61K31/683A61K31/685A61K31/688A61K35/32A61K35/42A61K35/50A61K35/586A61K35/618A61K35/648A61K36/076A61K36/185A61K36/23A61K36/27A61K36/31A61K36/66A61K36/70A61K36/704A61K36/71A61K36/80A61K36/815A61K36/8966A61K36/904A61K2236/15A61K2236/331A61K2236/39A61K2236/51C07J53/001A61K2300/00
Inventor 吴申龙
Owner 吴申龙
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products